Effective and Affordable Flu Vaccines for the World

Informacje na temat projektu

INDIGO

Identyfikator umowy o grant: 874653

DOI

10.3030/874653

Data podpisania przez KE 13 Grudnia 2019

Data rozpoczęcia 1 Kwietnia 2020

Data zakończenia 31 Marca 2026

Finansowanie w ramach

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Koszt całkowity

€ 16 000 968,00

Wkład UE

€ 9 975 979,00

Koordynowany przez

STICHTING AMSTERDAM UMC
Netherlands

CORDIS oferuje możliwość skorzystania z odnośników do publicznie dostępnych publikacji i rezultatów projektów realizowanych w ramach programów ramowych HORYZONT.

Odnośniki do rezultatów i publikacji związanych z poszczególnymi projektami 7PR, a także odnośniki do niektórych konkretnych kategorii wyników, takich jak zbiory danych i oprogramowanie, są dynamicznie pobierane z systemu OpenAIRE .

Rezultaty

Documents, reports (4)

Report on status of posting results in the study registry TETRA-LITE Phase I (EU)

Report on the status of the results posting including timelines when final posting of results is scheduled after end of funding period of Phase I trial TETRA-LITE (EU).

Publication LVA and MDPA adjuvants on human PBMCs

Publication LVA and MDPA adjuvants on human PBMCs and DCs

Report/Publication protective immunity TETRA-LITE in ferrets

ReportPublication protective immunity TETRALITE in ferrets

Report/Publication mode of action LVA for CTA

ReportPublication mode of action LVA for CTA

Websites, patent fillings, videos etc. (1)

Website, Facebook, etc.

Website Facebook etc

Publikacje

Peer reviewed articles (14)

A Novel Carbohydrate Fatty-Acid Monosulphate Ester, Squalane-in-Water Adjuvant Is Safe and Enhances Inactivated Influenza Vaccine Immunogenicity in Older Adults

Autorzy: Valentino D’Onofrio, Bart Jacobs, Azhar Alhatemi, Simon De Gussem, Marjolein Verstraete, Sharon Porrez, Anthony Willems, Fien De Boever, Gwenn Waerlop, Geert Leroux-Roels, Els Michels, Francesca Van
Opublikowane w: Vaccines, Numer 13, 2025, Strona(/y) 922, ISSN 2076-393X
Wydawca: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/vaccines13090922

Influenza vaccination uptake of health care workers in a tertiary hospital: Findings from qualitative research in Mysuru, India

Autorzy: Jantine Marly van Wijlick, K. S. Sahana, P. A. Mahesh, B. S. Jayaraj, Gangadhar Mysore Rajagopal, Christopher Pell
Opublikowane w: Global Public Health, Numer 20, 2025, ISSN 1744-1692
Wydawca: Routledge
DOI: 10.1080/17441692.2025.2541228

TRIPS at thirty: The evolving interactional law of public health exceptions to intellectual property protection

Autorzy: Geraldo Vidigal; Pramiti Parwani
Opublikowane w: VANDERBILT JOURNAL OF TRANSNATIONAL LAW, Numer 57, 2024, Strona(/y) 1493–1494, ISSN 0090-2594
Wydawca: University of Vanderbilt Law School
DOI: 10.3316/informit.t2025020500004891207935195

Influenza vaccination post-COVID-19 expands vaccine-specific effector CD4 T-cells and Tregs under positive influence of host trained innate immunity

Autorzy: Hima Bindhu, Srabanti Rakshit, Vasista Adiga, Asma Ahmed, Nirutha Chetan Kumar, Maria Macrina, Himanshu Tripathi, Francesca Vanni, Emanuele Montomoli, Sweety Samal, Sneha Raj, Preeti Vishwakarma, Geor
Opublikowane w: npj Vaccines, Numer 11, 2026, ISSN 2059-0105
Wydawca: Springer Science and Business Media LLC
DOI: 10.1038/s41541-025-01331-6

Retrospective analysis on the immunopotentiating mechanism of an emulsion-based vaccine adjuvant on human antigen presenting cells

Autorzy: Srinivasa Reddy Bonam, Peter Paul Platenburg and Jagadeesh Bayry
Opublikowane w: Frontiers Immunology, Numer 9 January 2023, 2023, ISSN 1664-3224
Wydawca: Frontiers in immunology

Perceptions of respiratory tract infections and their implications for disease prevention practices among older adults in Mysuru, India

Autorzy: Jantine Marly van Wijlick, K.S. Sahana, B.S. Jayaraj, Christopher Pell, Gangadhar Mysore Rajagopal, P. A. Mahesh
Opublikowane w: PLOS Global Public Health, Numer 5, 2025, Strona(/y) e0004982, ISSN 2767-3375
Wydawca: Public Library of Science (PLoS)
DOI: 10.1371/journal.pgph.0004982

Influenza vaccine hesitancy and acceptance among healthcare workers: A qualitative study in Amsterdam, the Netherlands / Grippeimpfung: Skepsis und Akzeptanz bei Gesundheitsfachkräften. Eine qualitat

Autorzy: Julia M. van Beekum, Jantine M. van Wijlick, Jaap Maas, Christopher Pell
Opublikowane w: International Journal of Health Professions, Numer 12, 2025, Strona(/y) 93-103, ISSN 2296-990X
Wydawca: Walter de Gruyter GmbH
DOI: 10.2478/ijhp-2025-0008

Intradermal Immunization of Soluble Influenza HA Derived from a Lethal Virus Induces High Magnitude and Breadth of Antibody Responses and Provides Complete Protection In Vivo

Autorzy: Sneha Raj, Preeti Vishwakarma, Shikha Saxena, Varun Kumar, Ritika Khatri, Amit Kumar, Mrityunjay Singh, Surbhi Mishra, Shailendra Asthana, Shubbir Ahmed, Sweety Samal
Opublikowane w: Vaccines, Numer 11, 2023, Strona(/y) 780, ISSN 2076-393X
Wydawca: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/vaccines11040780

Safety and Immunogenicity of a Carbohydrate Fatty Acid Monosulphate Ester Adjuvant Combined with a Low-Dose Quadrivalent Split-Virion Inactivated Influenza Vaccine: A Randomised, Observer-Blind, Active-Controlled, First-in-Human, Phase 1 Study

Autorzy: Valentino D’Onofrio, Sharon Porrez, Bart Jacobs, Azhar Alhatemi, Fien De Boever, Gwenn Waerlop, Els Michels, Francesca Vanni, Alessandro Manenti, Geert Leroux-Roels, Peter Paul Platenburg, Luuk Hilgers, Isabel Leroux-Roels
Opublikowane w: Vaccines, Numer 12, 2024, Strona(/y) 1036, ISSN 2076-393X
Wydawca: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/vaccines12091036

Carbohydrate fatty acid monosulphate ester is a potent adjuvant for low-dose seasonal influenza vaccines

Autorzy: Peter Paul L.I. Platenburg, Frantz Deschamps, Jennifer Jung, Clément Leonard, Séverine Rusconi, S.B. Mohan Kumar, S.M. Sulaiman, Leon de Waal, Luuk A. Th. Hilgers
Opublikowane w: Vaccine, Numer 41, 2023, Strona(/y) 6980-6990, ISSN 0264-410X
Wydawca: Elsevier BV
DOI: 10.1016/j.vaccine.2023.10.017

Factors affecting influenza vaccine uptake among healthcare providers at a tertiary hospital in Mysuru, India: a questionnaire-based survey

Autorzy: Naviya Kafle, Jantine van Wijlick, P. Chaithra Poonacha, P. Priyanka, Jiten Choudhury, N. Onkar Yadav, R. Nisarga, Rebecca D. Kehm, Logan Stuck, Christopher Pell, Anil S. Bilimale
Opublikowane w: Vaccine: X, Numer 25, 2025, Strona(/y) 100687, ISSN 2590-1362
Wydawca: Elsevier BV
DOI: 10.1016/j.jvacx.2025.100687

Trust Beyond Borders: European External Regulatory Influence on Access to Medicines

Autorzy: Pramiti Parwani, Katrina Perehudoff, Anniek de Ruijter
Opublikowane w: Journal of Law, Medicine & Ethics, Numer 53, 2025, Strona(/y) 365-378, ISSN 1073-1105
Wydawca: American Society of Law, Medicine & Ethics
DOI: 10.1017/jme.2025.10140

From human rights to the pandemic agreement and beyond: reframing vaccines access through a framework of ‘States’ capabilities’

Autorzy: Pramiti Parwani
Opublikowane w: Journal of Global Health Law, Numer 2, 2025, Strona(/y) 55-79, ISSN 2976-5951
Wydawca: Edward Elgar Publishing
DOI: 10.4337/jghl.2025.01.03

Decoding the Tecfidera Case: The Court of Justice of the European Union’s Verdict on the “Same Global Marketing Authorisation”

Autorzy: Pramiti Parwani
Opublikowane w: SSRN Electronic Journal, 2025, ISSN 1556-5068
Wydawca: Elsevier BV
DOI: 10.2139/ssrn.5153591

Thesis and dissertations (1)

States capabilities of least-developed countries to access pandemic vaccines. EU and India's legal and regulatory influence

Autorzy: P. Parwani
Opublikowane w: 2025
Wydawca: Library of the University of Amsterdam